Invacare CORP Stock: price and management transactions · United States · SEC (Form 4)Follow the Invacare CORP stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Invacare CORP has logged 50 public disclosures. The latest transaction was reported on 24 April 2023 (Disposition). Among the most active insiders: LaPlaca Anthony. All data is accessible without an account.
€97,218
14 ops.
Sell Volume
Buys €707,848 €97,218 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 April 2023
All Executives50 Thresholds0 Prospectus0 Other0
Declarations 50 total
● Director · Executives · 24 Apr 2023
39,474 shares 0Common Shares SEC:0001209191-23-025433:0
● Director · Executives · 24 Apr 2023
39,474 shares 0Common Shares SEC:0001209191-23-025453:0
● Director · Executives · 24 Apr 2023
39,474 shares 0Common Shares SEC:0001209191-23-025444:0
● Senior VP and CFO · Executives · 24 Apr 2023
108,163 shares 0Common Shares SEC:0001209191-23-025438:0
● Director · Executives · 24 Apr 2023
154,852 shares 0Common Shares SEC:0001209191-23-025440:0
● Director · Executives · 24 Apr 2023
39,474 shares 0Common Shares SEC:0001209191-23-025430:0
● Sr. VP and General Counsel · Executives · 24 Apr 2023
30,419 shares 0Common Shares SEC:0001209191-23-025436:0
● President and CEO · Executives · 24 Apr 2023
128,293 shares 0Common Shares SEC:0001209191-23-025450:0
● President and CEO · Executives · 20 Feb 2023
1,666 shares 0Common Shares SEC:0001209191-23-013820:0
▼ Director · Executives · 17 Nov 2022
20,000 shares @ US$0.453 1.3% of flow Common Shares, no par value SEC:0000899243-22-036592:0
● Director · Executives · 21 Nov 2022
24,671 shares 0Common Shares, no par value SEC:0000899243-22-036593:0
▼ Director · Executives · 14 Nov 2022
60,480 shares @ US$0.502 4.4% of flow Common Shares, no par value SEC:0000899243-22-036080:0
◆ Director · Executives · 13 Sept 2022
154,852 shares 0Common Shares SEC:0001209191-22-050157:0
◆ President and CEO · Executives · 13 Sept 2022
100,000 shares 0Common Shares SEC:0001209191-22-050159:0
◆ Director · Executives · 22 Aug 2022
24,671 shares 0Common Shares, no par value SEC:0000899243-22-029709:0
◆ Director · Executives · 22 Aug 2022
24,671 shares 0Common Shares, no par value SEC:0000899243-22-029710:0
100,000 shares @ US$1.44 20.7% of flow Common Shares, no par value SEC:0000899243-22-024350:0
Canonical exit: 19 Sept 2022 (T+90) 241,720 shares @ US$1.081 50.0% of flow Common Shares, no par value SEC:0000899243-22-021548:0
Canonical exit: 1 Sept 2022 (T+90) 241,720 shares @ US$1.081 50.0% of flow Common Shares, no par value SEC:0000899243-22-021417:0
Canonical exit: 1 Sept 2022 (T+90) ● Sr. VP and GM, North America · Executives · 15 May 2022
2,802 shares @ US$1.09 24.7% of flow Common Shares SEC:0001209191-22-029727:0
● Chairman, President and CEO · Executives · 15 May 2022
47,445 shares @ US$1.09 5.0% of flow Common Shares SEC:0001209191-22-029749:0
● SVP & GM, EMEA & Asia Pacific · Executives · 15 May 2022
1,602 shares @ US$1.09 100.0% of flow Common Shares SEC:0001209191-22-029756:0
● Sr. VP and General Counsel · Executives · 15 May 2022
3,116 shares @ US$1.09 4.5% of flow Common Shares SEC:0001209191-22-029737:0
● Chief Information Officer · Executives · 15 May 2022
1,664 shares @ US$1.09 13.1% of flow Common Shares SEC:0001209191-22-029732:0
● Senior VP and CFO · Executives · 15 May 2022
10,125 shares @ US$1.09 6.0% of flow Common Shares SEC:0001209191-22-029743:0
25 of 50 declarations
Load more (25 remaining) 关于 Invacare CORP Invacare Corp.(纽约证券交易所代码:IVC)是一家在美国纽约证券交易所上市的医疗设备公司。公司总部位于俄亥俄州埃利里亚,业务专注于非急性护理、家庭护理和康复导向型医疗设备。其核心价值主张是设计、制造和销售支持患者在家庭、长期护理和康复环境中实现活动能力、定位、日常生活和独立性的产品。([invacare.com](https://www.invacare.com/?utm_source=openai))
Invacare的历史可追溯至1979年12月,当时其成为独立企业。早期,公司的产品组合相对有限,主要集中在标准轮椅和患者辅助用品,但随着时间推移,公司建立了更广泛的产品组合和销售网络。这段历史对投资者很重要,因为它有助于解释公司在辅助和家庭医疗产品领域长期以来的品牌认知度。([sec.gov](https://www.sec.gov/Archives/edgar/data/742112/000074211217000019/a2016ivc10-k.htm?utm_source=openai))
如今,公司的主要业务线集中在活动能力和座椅系统,辅以生活方式和日常生活解决方案。其产品组合包括手动轮椅、电动轮椅、座椅和定位系统、患者转移和沐浴设备、治疗床和床垫、患者提升机和吊带,以及个人护理辅助用品。在最近的公司沟通中,Invacare描述了一项战略调整,重点关注其核心生活方式和活动能力及座椅系统类别,同时退出或淡化非核心业务。([global.invacare.com](https://global.invacare.com/news/invacare-holdings-corporation-and-miga-holdings-llc-announce-migas-acquisition-of-invacares-north-american-business/?utm_source=openai))
从竞争角度看,Invacare在医疗设备市场的专业细分领域运营,而非大众消费医疗保健市场。其差异化优势来自临床相关性、产品广度和与家庭医疗设备提供商、零售和电子商务合作伙伴、住宅护理运营商、经销商和政府卫生服务的渠道关系。公司的竞争对手包括区域专家和更大型的医疗设备供应商,使得执行力、产品创新和报销动态变得尤为重要。([sec.gov](https://www.sec.gov/Archives/edgar/data/742112/000095015207001879/l24944be10vkza.htm?utm_source=openai))
从地理位置看,Invacare历来通过国际销售网络服务北美、欧洲和亚太地区。最近的披露表明EMEA和APAC业务进一步调整,以及更广泛的运营结构简化,这表明管理层优先考虑资本效率和运营专注,而非全球覆盖本身。([newsroom.invacare.com](https://newsroom.invacare.com/news/invacare-corporation-announces-strategic-realignment-of-emea-apac-businesses/?utm_source=openai))
最近的里程碑集中在重组和产品组合理性化。Invacare于2023年5月从第11章破产中脱离,此后将其战略框架定位于运营卓越和核心产品类别的盈利长期增长。对股权投资者而言,这意味着该股票仍然是一个转型故事:一家历史悠久的美国纽约证券交易所上市医疗设备供应商,拥有公认的品牌,但同时面临报销压力、供应链执行和转型速度转化为可持续增长的风险。([newsroom.invacare.com](https://newsroom.invacare.com/news/invacare-holdings-corporation-completes-financial-restructuring-and-is-well-positioned-to-drive-forward-in-its-transformation/?utm_source=openai))